RT Book, Section A1 Wyer, Peter A1 Cook, Deborah J. A1 Vandvik, Per Olav A1 Richardson, W. Scott A1 Elbarbary, Mahmoud A1 Kunz, Regina A1 Wilson, Mark C. A2 Guyatt, Gordon A2 Rennie, Drummond A2 Meade, Maureen O. A2 Cook, Deborah J. SR Print(0) ID 1183878585 T1 Teachers' Guides to the Users' Guides T2 Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 978-0-07-179071-0 LK jamaevidence.mhmedical.com/content.aspx?aid=1183878585 RD 2024/10/13 AB CLINICAL SCENARIOScenario 1You are an attending physician in your hospital's intensive care unit (ICU) doing morning rounds on a patient with septic shock. The resident notes that the patient is still hypotensive after receiving 5 L of intravenous Ringer's lactate solution and asks if starch solution should be administered.Scenario 2You are awaiting the noon conference in the ICU where a patient admitted that week will be discussed in detail with 2 attending physicians, a fellow, 2 senior residents, and 2 junior residents. The fellow is now addressing preventive interventions as part of admission orders, noting that this patient did not receive heparin thromboprophylaxis when first admitted because his admitting diagnosis was ruptured abdominal aortic aneurysm. Now, 2 days after the patient's surgery, the fellow is wondering which type of heparin to prescribe.Scenario 3You are the faculty adviser for journal club in your surgical residency program. The resident assigned to lead this month's session attended the patient admitted from the emergency department with ruptured aortic aneurysm from scenario 2. She proposes to review the literature on the choice of low-molecular-weight heparin vs other prophylactic alternatives for postoperative patients.